Retraction Note: Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer

Ngā tūemi rite

• Retraction Note: Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer
  mā: Mohamed A. Alfaleh, me ētahi atu.
  I whakaputaina: (2024-11-01)
• The Encapsulation of Febuxostat into Emulsomes Strongly Enhances the Cytotoxic Potential of the Drug on HCT 116 Colon Cancer Cells
  mā: Usama A. Fahmy, me ētahi atu.
  I whakaputaina: (2020-10-01)
• Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic Cells
  mā: Nabil A. Alhakamy, me ētahi atu.
  I whakaputaina: (2021-12-01)
• Ceftriaxone and Melittin Synergistically Promote Wound Healing in Diabetic Rats
  mā: Nabil A. Alhakamy, me ētahi atu.
  I whakaputaina: (2021-10-01)
• Formulation Design, Statistical Optimization, and In Vitro Evaluation of a Naringenin Nanoemulsion to Enhance Apoptotic Activity in A549 Lung Cancer Cells
  mā: Shadab Md, me ētahi atu.
  I whakaputaina: (2020-07-01)